- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Study from NCPA sheds new light on med synchronization programs
- Senate passes Drug Quality and Security Act
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
REDWOOD CITY, Calif. — British retail pharmacy chain Lloyds Pharmacy and U.S.-based Proteus Biochemical are collaborating to launch a digital health product that combines sensor-enabled tablets, a sensor patch and a mobile health application to help people with complex medication regimens and health issues.
The two companies announced Friday that they would work together to commercialize and launch Helius, which they said would provide "assurance and peace of mind" to patients and their families, friends and providers, and improve medication adherence.
"Lloyds Pharmacy is committed to improving positive health outcomes for patients, and the Helius system is an exciting development, which takes our current medication adherence offering to a whole new level," Lloyds Pharmacy healthcare services director Steve Gray said. "There is a huge problem with medicines not being taken correctly. Anyone taking several medications shows how easy it can be to lose track of whether or not you've taken the correct tablets that day."